메뉴 건너뛰기




Volumn 22, Issue 3 I, 2002, Pages

Pharmaceutical considerations in aerosol drug delivery

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; ANTIBIOTIC AGENT; CEFTAZIDIME; COLISTIN; PENICILLIN DERIVATIVE; PIPERACILLIN; TICARCILLIN; TOBRAMYCIN;

EID: 0036195602     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.22.6.80s.33907     Document Type: Conference Paper
Times cited : (29)

References (20)
  • 3
    • 0021020048 scopus 로고
    • Bioactivity of gentamicin in purulent sputum from patients with cystic fibrosis or bronchiectasis: Comparison with activity in serum
    • (1983) J Infect Dis , vol.148 , pp. 1069-1076
    • Levy, J.1    Smith, A.L.2    Kenny, M.A.3
  • 12
    • 0029067641 scopus 로고
    • Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: A short-term, double-blind study followed by six months open label treatment
    • (1995) Eur Respir J , vol.8 , pp. 954-958
    • Shah, P.I.1    Bush, A.2    Canny, G.J.3
  • 19
    • 0032840712 scopus 로고    scopus 로고
    • Use of aerosolized antibiotics in patients with cystic fibrosis. Consensus conference
    • (1999) Chest , vol.116 , pp. 775-788
    • Campbell, P.W.1    Saiman, L.2
  • 20
    • 13044254788 scopus 로고    scopus 로고
    • Epidemiologic study of cystic fibrosis: Design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada
    • (1999) Pediatr Pulmonol , vol.28 , pp. 231-241
    • Morgan, W.J.1    Butler, S.M.2    Johnson, C.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.